746.35999 USD
6.26
0.83%
Last update Dec 16, 3:59 PM EST
Market closed
Day range
734.71997
757.34998
Previous close
752.62000
Open
752.57001
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
746.36
6.26
0.83%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 3.8B 3.7B 3.0B 3.8B
Cost of revenue 521.6M 530.2M 464.3M 565.4M
Gross profit 3.2B 3.1B 2.6B 3.2B
Operating expense
Research & development 1.5B 1.4B 1.3B 1.4B
Selling general and admin 657.8M 634.2M 633M 792.2M
Other operating expenses -10M 15.5M
Operating income 1.1B 1.1B 591.7M 990.2M
Non operating interest income
Income 175.1M 174.8M 173.5M 183.1M
Expense 19.3M 3.6M 8.7M 10.5M
Other income expense 497.6M 268M 148.5M -204.7M
Pretax income 1.8B 1.5B 905M 958.1M
Tax provision 303.3M 127.1M 96.3M 40.4M
Net income 1.5B 1.4B 808.7M 917.7M
Basic EPS 14.1 13.2 7.6 8.5
Diluted EPS 13.6 12.8 7.3 8.1
Basic average shares 103.6M 105.1M 106.7M 107.6M
Diluted average shares 107.2M 108.6M 111.2M 113.8M
EBITDA 1.4B 1.4B 900.9M 1.3B
Net income from continuing op. 1.5B 1.4B 808.7M 917.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 51 minutes

20:08
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).